Analytical and Chemical Enhancements to Improve Efficacy and Accuracy of Therapeutic Oligonucleotides
See how top pharma players are addressing impure, unstable, and off-target oligos
Boosting the Efficacy of Safe, Scalable, & Precise Vaccines
Innovations in mRNA Technology, RNA Therapeutics, and Cancer Immunotherapy for 2024
.png)
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River
Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological
Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Antibody-based Therapies
Clesrovimab Shows Positive Results as Preventative Treatment for RSV in Pre-Term and Full-Term Infants
The phase IIb/III met both its primary and secondary endpoints in infants one year old or younger.
Regulatory
The NIST Awards $1.5 Million to Improve Standardisation in Regenerative Medicine
The National Institute of Standards and Technology (NIST) has given $1.5 million to two organisations to enhance regenerative medicine standards.
NextGen Therapeutics
Archon Biosciences Announces $20m of Seed Funding for its Nobel-Winning, AI-Driven Antibody Cage Technology
This investment signals the UW spin out’s ‘emergence from stealth’, showcasing their unique antibody platform.
Antibody-based Therapies
FDA Grant Rare Pediatric Disease Designation to Omeros’s Antibody for C3 Glomerulopathy
Rare pediatric disease designation allows the company to access priority review from the FDA for a new drug application or biologics licence application.
Medicinal Chemistry
Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
3D Cell Culture
MicroQuin’s Space-Based Research Uncovers New Pathways in Cancer Treatment
MicroQuin has teamed up with the International Space Station to explore the behaviour of cancer cells in space and the implications this could have for developing new treatments.
Immunotherapy (Non-Oncology)
Phase II Trial Begins for Recombinant Gelsolin as Immune Regulator in ARDS Patients
BioAegis’s recombinant human plasma gelsolin aims to address the inflammatory complications of ARDS.
.jpg)
Antibody & Protein Engineering
Q&A with Silvia Crescioli, Business Intelligence Creator, The Antibody Society
We catch up with Silvia Crescioli from The Antibody Society to unpack the latest trends and technologies fuelling progress in antibody therapeutic development.